Christopher Lee, DVM, explains Toxoplasma gondii facts: why most indoor cats rarely shed, plus pregnancy-safe litter tips for cat health
|Articles|October 1, 2006
Snap 4Dx test makes debut at CVC Central
WESTBROOK, MAINE - IDEXX Laboratories introduces the Snap 4Dx Test an in-house test that lets veterinarians screen for heartworm, ehrlichiosis, Lyme disease and anaplasmosis.
Advertisement
WESTBROOK, MAINE — IDEXX Laboratories introduces the Snap 4Dx Test an in-house test that lets veterinarians screen for heartworm, ehrlichiosis, Lyme disease and anaplasmosis. The company reports the test helps support veterinarians by managing the growing anaplasmosis incidence by:
- Finding the presence of Anaplasma phagocytophilum exposure—the tick-borne pathogen.
- Helping DVMs identify infected patients prone to clinical disease.
- Educate on the incidence of risk and disease in the area.
Advertisement
- Reinforce strategies for tick control and disease prevention.
The test is affordable and delivers accurate screening results with at least a 98-percent specificity on all four diseases, the company reports.
Dogs exposed to Anaplasma phagocytophilum (E. equi) are at risk for getting sick.
Supporting clinical signs for an anaplasmosis diagnosis are lameness, anorexia, petechia, lethargy and fever. Supporting CBC/chemistry evidence of anaplasmosis includes thrombocytopenia, lymphopenia, leukopenia and hyperglobulinemia, the company reports.
For fastest response, call
(800) 248-2483
Advertisement
Related to this article
The latest updates relating to animal care establishments and platforms.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option that is given twice weekly and showed a longer time to disease progression than control in a field study.
The first survey of parasite control on bison ranches shows most herds are dewormed on a schedule, with little testing to see whether they need it. Researchers say the habit could make resistance harder to manage.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Cheryl Stout, DVM, discusses her path from aspiring conservationist to residency-trained zoo veterinarian, her conservation goals, and her educational work on social media.
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
After more than 20 years of work toward its first rhino birth, the Texas ranch has now welcomed 3 calves in 3 years.
Advertisement
Advertisement
Trending on dvm360
1
Natural Bridge Wildlife Ranch welcomes third southern white rhino calf in 3 years
2
Bison producers deworm often but rarely test first, survey finds
3
A catastrophic miscarriage of justice: The truth about Toxoplasma gondii risk from household cats
4
Experimental drug found to slow bone cancer cell growth in dog and human lab tests
5